Retraction

Mocetinostat suppresses epidural fibrosis following laminectomy by inhibiting myofibroblast activation and increasing apoptosis

Retraction Details

Retraction Reason:

Error in Data

Nature of Retraction:

Retraction

Citations (3)

3
Total Citations
2
Post-Retraction
(66.7%)
0
Pre-Retraction
0
Same Day
Post-Retraction Citation Analysis
0 Within 30 days
2 Within 1 year
0 After 2+ years
296 Days since retraction (latest)
Heavy Metals Removal Using Carbon Based Nanocomposites
Unknown Authors
Unknown Journal
Published: Unknown
Tubastatin A suppresses the proliferation of fibroblasts in epidural fibrosis through phosphatidylinositol-3-kinase/protein kinase B/mammalian target of rapamycin (PI3K/AKT/mTOR) signalling pathway
Yang Liu, Ruihong Wang, Huimin Han et al. (4 authors)
Journal of Pharmacy and Pharmacology Open Access
Published: Feb 2022
4 citations
296 days after retraction
The contributing factors of resistance or sensitivity to epigenetic drugs in the treatment of AML
Shohre Karimi Kelaye, Fatemeh Najafi, Bahareh Kazemi et al. (7 authors)
Clinical & Translational Oncology
Published: Jan 2022
4 citations
269 days after retraction
Quick Stats
Total Citations: 4
Years Since Retraction: 4.6 years
Open Access: Yes
Last Checked: Jul 24, 2025
Related Papers
Effect of propofol on myocardial ischemia-reperfusion injur…
European Review for Medical and Pharmacological Sciences • 19 citations
MiR-299-3p inhibits proliferation and invasion of cervical …
European Review for Medical and Pharmacological Sciences • 19 citations
Aldose reductase inhibitor Epalrestat alleviates high gluco…
European Review for Medical and Pharmacological Sciences • 18 citations
MiR-15a-3p suppresses the growth and metastasis of ovarian …
European Review for Medical and Pharmacological Sciences • 18 citations
The inhibitory effect of miR-375 targeting sp1 in colorecta…
European Review for Medical and Pharmacological Sciences • 18 citations